Those Wanting To Lose Weight Will Have New Option After FDA's Approval of Belviq

Researchers say the drug does not have deadly side effects like others before it

By Christina Hernandez
|  Thursday, Jun 28, 2012  |  Updated 7:01 AM EDT
View Comments (
)
|
Email
|
Print
Belviq is the first weight loss drug approved by the Food and Drug Administration in more than 10 years. Researchers say it does not have deadly side effects like others before it. Anapoula Ferreria, nurse Sandra Foo and nurse Karen Manning talk to NBC 6.

Belviq is the first weight loss drug approved by the Food and Drug Administration in more than 10 years. Researchers say it does not have deadly side effects like others before it. Anapoula Ferreria, nurse Sandra Foo and nurse Karen Manning talk to NBC 6.

advertisement
Photos and Videos
More Photos and Videos

If you want to lose weight, there is a new drug on the market that may help you.

Belviq is the first weight loss drug approved by the Food and Drug Administration in more than 10 years. Researchers say it does not have deadly side effects like others before it.

Anapoula Ferreria has tried different weight loss pills before, but quit, not liking the way they made her feel.

"It's just the heart. I would shake, get nervous ... things like that," Ferreria said. "The heart would speed up. That's why I don't take anything."

The FDA says Belviq helps users lose at least 3 percent of their body weight, but the drug must be combined with exercise and healthy eating.

For nurse Karen Manning, it's too risky.

"There's always side effects to everything," she said. "You're always better doing it the natural way. Sometimes you don't find it till later. "

Click here to read about a teen who says gastric bypass surgery changed her life.

Like most weight loss pills, the drug works by blocking a specific receptor in the brain, and that makes user feel full after eating a small amount.

Some weight loss pills have been pulled from the market after causing heart problems. Researchers think it's because a certain receptor was activated on heart tissue.

"Remember Phen-Fen?" nurse Sandra Foo asked Manning.

"We had a patient with cardiac arrest," Manning replied.

According to the FDA, Belviq does not appear to activate that receptor.

Get more information about Belviq from the FDA here.

More Health News

Get the latest headlines sent to your inbox!
Posted Jun 27, 2012
Leave Comments
What's New
Get Our New iPad App
Now optimized for iPad, NBC 6 connects... Read more
Follow Us
Sign up to receive news and updates that matter to you.
Send Us Your Story Tips
Check Out